Would you recommend the following article to a politician, an athlete, a business executive, or a scientist?

Eyetech Pins Its Hopes (and Shares) on New Drug An experimental eye disease drug has been a boon to Eyetech Pharmaceuticals. But as the drug nears approval, many doctors are questioning its effectiveness.
